Novartis AG vs SiTime Corporation — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while SiTime Corporation trades at $598.54 (market cap $16.63B). The key difference: Novartis AG is far larger — about 17.5× SiTime Corporation's market cap, and Novartis AG pays a 3.17% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals.
| NVS | SITM | |
|---|---|---|
Market Cap | $290.25B | $16.63B |
Sector | Health | Technology |
52-Week High | $168.62 | $901.60 |
52-Week Low | $113.50 | $190.16 |
Enterprise Value | $330.27B | $15.84B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →